447 related articles for article (PubMed ID: 24437926)
1. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
[TBL] [Abstract][Full Text] [Related]
2. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
4. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
5. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles.
Dangi R; Hurkat P; Jain A; Shilpi S; Jain A; Gulbake A; Jain SK
J Microencapsul; 2014; 31(5):479-87. PubMed ID: 24697169
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
Leelakanok N; Geary SM; Salem AK
J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
[TBL] [Abstract][Full Text] [Related]
8. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
[TBL] [Abstract][Full Text] [Related]
9. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
10. Folate targeted polymeric 'green' nanotherapy for cancer.
Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
12. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
Mishra BJ; Kaul A; Trivedi P
Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408
[TBL] [Abstract][Full Text] [Related]
13. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
[TBL] [Abstract][Full Text] [Related]
14. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
15. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A.
Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
[TBL] [Abstract][Full Text] [Related]
17. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery.
Xin Y; Liu T; Yang C
Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]